LU45106A1 - - Google Patents

Info

Publication number
LU45106A1
LU45106A1 LU45106DA LU45106A1 LU 45106 A1 LU45106 A1 LU 45106A1 LU 45106D A LU45106D A LU 45106DA LU 45106 A1 LU45106 A1 LU 45106A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU45106A1 publication Critical patent/LU45106A1/xx

Links

LU45106D 1962-12-27 1963-12-23 LU45106A1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
LU45106A1 true LU45106A1 (ko) 1964-02-24

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
LU45106D LU45106A1 (ko) 1962-12-27 1963-12-23

Country Status (5)

Country Link
BE (1) BE641880A (ko)
FR (1) FR3150M (ko)
GB (1) GB1080599A (ko)
LU (1) LU45106A1 (ko)
NL (1) NL302572A (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
SI2153870T1 (sl) 2004-11-26 2014-05-30 Ucl Business Plc Sestavki, ki obsegajo ornitin in fenilacetat ali fenilbutirat, za zdravljenje hepatitične encefalopatije
PL2413924T3 (pl) 2009-04-03 2018-02-28 Ocera Therapeutics, Inc. Fenylooctan l-ornityny i sposoby jego wytwarzania
KR20170026672A (ko) 2009-06-08 2017-03-08 유씨엘 비즈니스 피엘씨 L―오르니틴 페닐아세테이트를 사용한 문맥압 항진증의 치료 및 간 기능 회복
TR201903978T4 (tr) 2010-10-06 2019-04-22 Ocera Therapeutics Inc L-ornitin fenil asetat yapım yöntemleri.
CN113633777A (zh) 2014-11-24 2021-11-12 Ucl商业有限公司 使用降氨疗法治疗与肝星状细胞激活相关的疾病
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CA3063134A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
GB1080599A (en) 1967-08-23
BE641880A (ko) 1964-04-16
FR3150M (fr) 1965-02-22
NL302572A (ko)

Similar Documents

Publication Publication Date Title
BE616548R (ko)
BE621553A (ko)
BE612464A (ko)
LU45106A1 (ko)
BE626971A (ko)
BE635240A (ko)
BE634821A (ko)
BE633765A (ko)
BE633687A (ko)
BE633210A (ko)
BE632887A (ko)
BE632633A (ko)
BE631376A (ko)
BE629169A (ko)
BE628347A (ko)
BE592434A (ko)
BE620644A (ko)
BE620399A (ko)
BE616785A (ko)
BE616490A (ko)
BE616386A (ko)
BE616166A (ko)
BE615962A (ko)
BE615849A (ko)
BE615804A (ko)